Cargando…

Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines

Lung cancer (LC) with its different subtypes is generally known as a therapy resistant cancer with the highest morbidity rate worldwide. Therapy resistance of a tumor is thought to be related to cancer stem cells (CSCs) within the tumors. There have been indications that the lung cancer is propagate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ping, Gao, Quanli, Suo, Zhenhe, Munthe, Else, Solberg, Steinar, Ma, Liwei, Wang, Mengyu, Westerdaal, Nomdo Anton Christiaan, Kvalheim, Gunnar, Gaudernack, Gustav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587631/ https://www.ncbi.nlm.nih.gov/pubmed/23469181 http://dx.doi.org/10.1371/journal.pone.0057020

Ejemplares similares

In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines
por: Wang, Ping, et al.
Publicado: (2013)

hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
por: Suso, Else M. Inderberg, et al.
Publicado: (2011)

T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth
por: Inderberg, Else M., et al.
Publicado: (2017)

A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines
por: Jarnjak-Jankovic, Silvija, et al.
Publicado: (2007)

Prostate Cancer Cell Lines under Hypoxia Exhibit Greater Stem-Like Properties
por: Ma, Yuanyuan, et al.
Publicado: (2011)

Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines
por: Ma, Yuanyuan, et al.
Publicado: (2012)

NK cells specifically TCR-dressed to kill cancer cells
por: Mensali, Nadia, et al.
Publicado: (2019)

Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
por: Mensali, Nadia, et al.
Publicado: (2019)

Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
por: Mensali, Nadia, et al.
Publicado: (2019)

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
por: Vik-Mo, Einar Osland, et al.
Publicado: (2013)

Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity
por: Mensali, Nadia, et al.
Publicado: (2019)

Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors
por: Dillard, Pierre, et al.
Publicado: (2021)

MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
por: Li, Xiaoran, et al.
Publicado: (2016)

A TCR-based Chimeric Antigen Receptor
por: Walseng, Even, et al.
Publicado: (2017)

Correction: MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
por: Li, Xiaoran, et al.
Publicado: (2017)

Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
por: Inderberg-Suso, Else-Marit, et al.
Publicado: (2012)

Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
por: Dillard, Pierre, et al.
Publicado: (2021)

Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
por: Li, Xiaoran, et al.
Publicado: (2017)

Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia
por: Jarnjak-Jankovic, Silvija, et al.
Publicado: (2005)

ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro
por: Yu, Dandan, et al.
Publicado: (2015)

Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer
por: Brunsvig, Paal F., et al.
Publicado: (2020)

Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
por: Mu, L J, et al.
Publicado: (2005)

Characterization of Liposarcoma Cell Lines for Preclinical and Biological Studies
por: Stratford, Eva W., et al.
Publicado: (2012)

Therapeutic cancer vaccination against telomerase: clinical developments in melanoma
por: Ellingsen, Espen Basmo, et al.
Publicado: (2023)

Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
por: Sioud, Mouldy, et al.
Publicado: (2016)

The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines
por: Wessel Stratford, Eva, et al.
Publicado: (2014)

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
por: Ellingsen, Espen Basmo, et al.
Publicado: (2022)

Generation and Characterisation of Novel Pancreatic Adenocarcinoma Xenograft Models and Corresponding Primary Cell Lines
por: Wennerström, Anna B., et al.
Publicado: (2014)

SHBG Is an Important Factor in Stemness Induction of Cells by DHT In Vitro and Associated with Poor Clinical Features of Prostate Carcinomas
por: Ma, Yuanyuan, et al.
Publicado: (2013)

Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing
por: Wang, Zhiru, et al.
Publicado: (2021)

Liposarcoma cells with aldefluor and CD133 activity have a cancer stem cell potential
por: Stratford, Eva W, et al.
Publicado: (2011)

A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)
por: Maggadóttir, Sólrún Melkorka, et al.
Publicado: (2022)

The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells
por: Liang, Dongming, et al.
Publicado: (2012)

Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis
por: Holm, Ruth, et al.
Publicado: (2008)

Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer
por: Xu, Benling, et al.
Publicado: (2015)

Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential
por: Ellingsen, Espen Basmo, et al.
Publicado: (2021)

PDHA1 Gene Knockout In Human Esophageal Squamous Cancer Cells Resulted In Greater Warburg Effect And Aggressive Features In Vitro And In Vivo
por: Liu, Lan, et al.
Publicado: (2019)

Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial
por: Aamdal, Elin, et al.
Publicado: (2021)

Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival
por: Mathiesen, Randi R, et al.
Publicado: (2012)

Dynamic peripheral blood immune cell markers for predicting the response of patients with metastatic cancer to immune checkpoint inhibitors
por: Wei, Chen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jj0don39vf40t0d9sacjjt6k7q